ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics

The pathogenic role of p-ANCA in eosinophilic granulomatosis with polyangiitis (EGPA) is a long-standing matter of debate. In this work, we report our real-life experience with EGPA patients, treated with biologics targeting type 2 (T2)-eosinophilic inflammation (Mepolizumab, Benralizumab, Dupilumab...

詳細記述

書誌詳細

出版年:	Frontiers in Immunology
主要な著者:	Mario Andrea Piga, Paolo Fraticelli, Leonardo Antonicelli, Maria Stella Garritani, Giulia Ghirelli, Matteo Martini, Angelica Di Vincenzo, Maria Giovanna Danieli, Gianluca Moroncini, Maria Beatrice Bilò
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2023-11-01
主題:	ANCA biologics EGPA eosinophils vasculitis
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1325299/full